Schering Sues Barr Over Brain Tumor Drug

Law360, New York (July 24, 2007, 12:00 AM EDT) -- Pharmaceutical company Schering Corp. filed suit against generic maker Barr Pharmaceuticals Inc. on Friday, alleging infringement of a patent covering Schering’s brain tumor treatment, Temodar.

Schering filed the complaint in the U.S. District Court for the District of Delaware along with patent holder Cancer Research Technology Ltd., a British research company that licensed the use of its patent exclusively to Schering. The companies claim that Barr and its subsidiary Barr Laboratories Inc. have infringed on their patent in their Abbreviated New Drug Application, filed with the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.